Qiagen
In Brief This Week: NeoGenomics; Labcorp; Qiagen; Siemens Healthineers; Indica Labs
News items for the week of April 7, 2025.
Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.
Qiagen Preliminary Q1 Net Sales Up 5 Percent, Firm Raises 2025 EPS Estimate
The firm's guidance raise was seen by analysts as a positive indicator for companies with recurring NIH revenues.
360Dx Top 30 Slides 5 Percent in March
Of the 30 companies, three saw their stock prices increase, 26 saw their share prices decline, and one company's share price remained virtually flat month over month.
Top Five Articles on 360Dx Last Week: Qiagen, BioMérieux Lawsuit; T2 Biosystems Post-Mortem; More
Last week, readers were most interested in a story about a lawsuit brought forth by Qiagen against BioMérieux in Germany.
Jan 10, 2025
FDA Clears Qiagen's Five-Target Syndromic GI Panel
Oct 29, 2024
FDA Clears Qiagen QiaStat-Dx Respiratory Mini Panel
Aug 23, 2024